Denmark
Add to My Companies | Give a Referral for this Company | Print this ProfileThe latest news, announcements and press releases from Fertin Pharma As.
EQT announced today that it has agreed to sell Fertin Pharma, a specialist contract development and manufacturing organization (CDMO) in innovative oral and intra-oral delivery technologies, to Philip Morris International (PMI) (NYSE: PM).
With headquarters in Vejle, Denmark, Fertin Pharma is a leading specialist CDMO in innovative oral and intra-oral delivery technologies to support healthier living. The Company develops and manufactures innovative delivery systems, such as chewing gums, tablets, and powders, used for pharmaceutical and nutraceutical applications. Innovative and consumer relevant solutions that when consumed enhance the efficacy of active and functional ingredients.
This is the News section of the company profile page for Fertin Pharma As on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
